Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
Source: Definitions of Medicare Code Edits v44.0, edit 9.
Advertisements
Codes on this list
2,666 codes, page 8 of 27.
- T40.5X5DAdverse effect of cocaine, subsequent encounter
- T40.5X5SAdverse effect of cocaine, sequela
- T40.5X6AUnderdosing of cocaine, initial encounter
- T40.5X6DUnderdosing of cocaine, subsequent encounter
- T40.5X6SUnderdosing of cocaine, sequela
- T40.605AAdverse effect of unspecified narcotics, initial encounter
- T40.605DAdverse effect of unspecified narcotics, subsequent encounter
- T40.605SAdverse effect of unspecified narcotics, sequela
- T40.606AUnderdosing of unspecified narcotics, initial encounter
- T40.606DUnderdosing of unspecified narcotics, subsequent encounter
- T40.606SUnderdosing of unspecified narcotics, sequela
- T40.695AAdverse effect of other narcotics, initial encounter
- T40.695DAdverse effect of other narcotics, subsequent encounter
- T40.695SAdverse effect of other narcotics, sequela
- T40.696AUnderdosing of other narcotics, initial encounter
- T40.696DUnderdosing of other narcotics, subsequent encounter
- T40.696SUnderdosing of other narcotics, sequela
- T40.715AAdverse effect of cannabis, initial encounter
- T40.715DAdverse effect of cannabis, subsequent encounter
- T40.715SAdverse effect of cannabis, sequela
- T40.716AUnderdosing of cannabis, initial encounter
- T40.716DUnderdosing of cannabis, subsequent encounter
- T40.716SUnderdosing of cannabis, sequela
- T40.725AAdverse effect of synthetic cannabinoids, initial encounter
- T40.725DAdverse effect of synthetic cannabinoids, subsequent encounter
- T40.725SAdverse effect of synthetic cannabinoids, sequela
- T40.726AUnderdosing of synthetic cannabinoids, initial encounter
- T40.726DUnderdosing of synthetic cannabinoids, subsequent encounter
- T40.726SUnderdosing of synthetic cannabinoids, sequela
- T40.905AAdverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
- T40.905DAdverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
- T40.905SAdverse effect of unspecified psychodysleptics [hallucinogens], sequela
- T40.906AUnderdosing of unspecified psychodysleptics [hallucinogens], initial encounter
- T40.906DUnderdosing of unspecified psychodysleptics [hallucinogens], subsequent encounter
- T40.906SUnderdosing of unspecified psychodysleptics [hallucinogens], sequela
- T40.995AAdverse effect of other psychodysleptics [hallucinogens], initial encounter
- T40.995DAdverse effect of other psychodysleptics [hallucinogens], subsequent encounter
- T40.995SAdverse effect of other psychodysleptics [hallucinogens], sequela
- T40.996AUnderdosing of other psychodysleptics [hallucinogens], initial encounter
- T40.996DUnderdosing of other psychodysleptics [hallucinogens], subsequent encounter
- T40.996SUnderdosing of other psychodysleptics [hallucinogens], sequela
- T41.0X5AAdverse effect of inhaled anesthetics, initial encounter
- T41.0X5DAdverse effect of inhaled anesthetics, subsequent encounter
- T41.0X5SAdverse effect of inhaled anesthetics, sequela
- T41.0X6AUnderdosing of inhaled anesthetics, initial encounter
- T41.0X6DUnderdosing of inhaled anesthetics, subsequent encounter
- T41.0X6SUnderdosing of inhaled anesthetics, sequela
- T41.1X5AAdverse effect of intravenous anesthetics, initial encounter
- T41.1X5DAdverse effect of intravenous anesthetics, subsequent encounter
- T41.1X5SAdverse effect of intravenous anesthetics, sequela
- T41.1X6AUnderdosing of intravenous anesthetics, initial encounter
- T41.1X6DUnderdosing of intravenous anesthetics, subsequent encounter
- T41.1X6SUnderdosing of intravenous anesthetics, sequela
- T41.205AAdverse effect of unspecified general anesthetics, initial encounter
- T41.205DAdverse effect of unspecified general anesthetics, subsequent encounter
- T41.205SAdverse effect of unspecified general anesthetics, sequela
- T41.206AUnderdosing of unspecified general anesthetics, initial encounter
- T41.206DUnderdosing of unspecified general anesthetics, subsequent encounter
- T41.206SUnderdosing of unspecified general anesthetics, sequela
- T41.295AAdverse effect of other general anesthetics, initial encounter
- T41.295DAdverse effect of other general anesthetics, subsequent encounter
- T41.295SAdverse effect of other general anesthetics, sequela
- T41.296AUnderdosing of other general anesthetics, initial encounter
- T41.296DUnderdosing of other general anesthetics, subsequent encounter
- T41.296SUnderdosing of other general anesthetics, sequela
- T41.3X5AAdverse effect of local anesthetics, initial encounter
- T41.3X5DAdverse effect of local anesthetics, subsequent encounter
- T41.3X5SAdverse effect of local anesthetics, sequela
- T41.3X6AUnderdosing of local anesthetics, initial encounter
- T41.3X6DUnderdosing of local anesthetics, subsequent encounter
- T41.3X6SUnderdosing of local anesthetics, sequela
- T41.45XAAdverse effect of unspecified anesthetic, initial encounter
- T41.45XDAdverse effect of unspecified anesthetic, subsequent encounter
- T41.45XSAdverse effect of unspecified anesthetic, sequela
- T41.46XAUnderdosing of unspecified anesthetics, initial encounter
- T41.46XDUnderdosing of unspecified anesthetics, subsequent encounter
- T41.46XSUnderdosing of unspecified anesthetics, sequela
- T41.5X5AAdverse effect of therapeutic gases, initial encounter
- T41.5X5DAdverse effect of therapeutic gases, subsequent encounter
- T41.5X5SAdverse effect of therapeutic gases, sequela
- T41.5X6AUnderdosing of therapeutic gases, initial encounter
- T41.5X6DUnderdosing of therapeutic gases, subsequent encounter
- T41.5X6SUnderdosing of therapeutic gases, sequela
- T42.0X5AAdverse effect of hydantoin derivatives, initial encounter
- T42.0X5DAdverse effect of hydantoin derivatives, subsequent encounter
- T42.0X5SAdverse effect of hydantoin derivatives, sequela
- T42.0X6AUnderdosing of hydantoin derivatives, initial encounter
- T42.0X6DUnderdosing of hydantoin derivatives, subsequent encounter
- T42.0X6SUnderdosing of hydantoin derivatives, sequela
- T42.1X5AAdverse effect of iminostilbenes, initial encounter
- T42.1X5DAdverse effect of iminostilbenes, subsequent encounter
- T42.1X5SAdverse effect of iminostilbenes, sequela
- T42.1X6AUnderdosing of iminostilbenes, initial encounter
- T42.1X6DUnderdosing of iminostilbenes, subsequent encounter
- T42.1X6SUnderdosing of iminostilbenes, sequela
- T42.2X5AAdverse effect of succinimides and oxazolidinediones, initial encounter
- T42.2X5DAdverse effect of succinimides and oxazolidinediones, subsequent encounter
- T42.2X5SAdverse effect of succinimides and oxazolidinediones, sequela
- T42.2X6AUnderdosing of succinimides and oxazolidinediones, initial encounter
- T42.2X6DUnderdosing of succinimides and oxazolidinediones, subsequent encounter